By Nate Raymond BOSTON (Reuters) - A medical device company has agreed to pay $42 million and plead guilty to resolve U.S. charges that it concealed a .
Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.
Update Magellan Diagnostics to pay $42M to settle lead case bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.
Medical device company to pay $42 million to resolve US lead-testing defect charges yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
BOSTON — A medical device company headquartered in Billerica, Mass., has agreed to pay $42 million and plead guilty to resolve charges that it concealed a malfunction in its lead-testing